library_books The Cancer Institute NSW is now in its sixth year of operation and our expenditure on cancer research has grown significantly over this period.

library_books Between 17-50% of people with brain tumour (BT) display some degree of challenging behaviour (CB) including executive impairment, behavioural disturbance, or social/emotional dysfunction. However, little information on management strategies is available for patients and/or their carers to assist in coping with these problems.

library_books As part of a wider study on patterns of melanoma care in NSW, histopathology reports of all primary invasive melanomas notified to the NSW Central Cancer Registry between 23/10/2006 to 22/10/2007 (n = 3784) were collated and reviewed.

library_books Brain tumours (BT) can cause impairments in behavioural disturbance and higher order cognitive functioning (also known as executive dysfunction) but there has been limited investigation into the extent of such problems.

library_books Cognitive and behavioural changes have been noted in patients diagnosed with a brain tumour (BT). Both patients and family members report that dealing with such changes can prove to be overwhelming and distressing, yet little is known about the extent of these impairments and importantly, suitable management approaches.

library_books Health professionals who care for patients diagnosed with primary brain tumours often report behavioural and cognitive changes. These changes can present management challenges for staff especially where generalist staff may not be equipped to care for such sequelae.

library_books Developments in cancer research offer hope that the gains we have seen recently can be accelerated across a range of cancers. Cancer death rates have fallen by around 20 per cent in some common cancers, such as bowel, breast and prostate cancer. Unfortunately, other cancers, like lung, brain and upper gastrointestinal cancer, still need more focused work.

library_books Investment in cancer research has become a priority across the world, acknowledging the rising burden of cancer on society and in particular on healthcare budgets. There are compelling reasons for New South Wales to continue to be an active participant in world-class biomedical and health research and particularly in areas such as cancer.

library_books In 2006, New South Wales entered a period of unprecedented tobacco control activity which included ongoing Cancer Institute NSW quit smoking mass media campaigns, introduction of graphic health warnings on cigarette packs and tighter restrictions on smoking in licensed venues.